127 related articles for article (PubMed ID: 10098677)
1. Solid-phase synthesis of novel inhibitors of farnesyl transferase.
Barber AM; Hardcastle IR; Rowlands MG; Nutley BP; Marriott JH; Jarman M
Bioorg Med Chem Lett; 1999 Feb; 9(4):623-6. PubMed ID: 10098677
[TBL] [Abstract][Full Text] [Related]
2. Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors.
Angibaud P; Bourdrez X; End DW; Freyne E; Janicot M; Lezouret P; Ligny Y; Mannens G; Damsch S; Mevellec L; Meyer C; Muller P; Pilatte I; Poncelet V; Roux B; Smets G; Van Dun J; Van Remoortere P; Venet M; Wouters W
Bioorg Med Chem Lett; 2003 Dec; 13(24):4365-9. PubMed ID: 14643327
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective farnesyl transferase inhibitors.
Millet R; Domarkas J; Houssin R; Gilleron P; Goossens JF; Chavatte P; Logé C; Pommery N; Pommery J; Hénichart JP
J Med Chem; 2004 Dec; 47(27):6812-20. PubMed ID: 15615530
[TBL] [Abstract][Full Text] [Related]
4. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
Mitsch A; Böhm M; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors.
Reuveni H; Gitler A; Poradosu E; Gilon C; Levitzki A
Bioorg Med Chem; 1997 Jan; 5(1):85-92. PubMed ID: 9043660
[TBL] [Abstract][Full Text] [Related]
6. Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors.
Le Diguarher T; Ortuno JC; Dorey G; Shanks D; Guilbaud N; Pierré A; Fauchère JL; Hickman JA; Tucker GC; Casara PJ
Bioorg Med Chem; 2003 Jul; 11(14):3193-204. PubMed ID: 12818682
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.
Le Diguarher T; Ortuno JC; Shanks D; Guilbaud N; Pierré A; Raimbaud E; Fauchère JL; Hickman JA; Tucker GC; Casara PJ
Bioorg Med Chem Lett; 2004 Feb; 14(3):767-71. PubMed ID: 14741286
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of isorhamnetin from Persicaria thunbergii on Farnesyl Protein Transferase.
Oh HM; Kwon BM; Baek NI; Kim SH; Chung IS; Park MH; Park HW; Lee JH; Park HW; Kim EJ; Kim DK
Arch Pharm Res; 2005 Feb; 28(2):169-71. PubMed ID: 15789745
[TBL] [Abstract][Full Text] [Related]
9. Aromatic carboxylic acids as farnesyl surrogates in farnesylpyrophosphate-based farnesyltransferase inhibitors.
Schlitzer M; Sattler I
Bioorg Med Chem; 1999 Nov; 7(11):2391-5. PubMed ID: 10632048
[TBL] [Abstract][Full Text] [Related]
10. Stable analogues of geranylgeranyl diphosphate possessing improved geranylgeranyl versus farnesyl protein transferase inhibitory selectivity.
Minutolo F; Bertini S; Betti L; Danesi R; Gervasi G; Giannaccini G; Papi C; Placanica G; Barontini S; Rapposelli S; Macchia M
Bioorg Med Chem Lett; 2003 Dec; 13(24):4405-8. PubMed ID: 14643335
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferase.
Stöber P; Schelhaas M; Nägele E; Hagenbuch P; Rétey J; Waldmann H
Bioorg Med Chem; 1997 Jan; 5(1):75-83. PubMed ID: 9043659
[TBL] [Abstract][Full Text] [Related]
12. Preparation of alpha-phosphono lactams via electrophilic phosphorus reagents: an application in the synthesis of lactam-based farnesyl transferase Inhibitors.
Du Y; Wiemer DF
J Org Chem; 2002 Aug; 67(16):5709-17. PubMed ID: 12153273
[TBL] [Abstract][Full Text] [Related]
13. Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase.
Silverman KC; Cascales C; Genilloud O; Sigmund JM; Gartner SE; Koch GE; Gagliardi MM; Heimbuch BK; Nallin-Omstead M; Sanchez M
Appl Microbiol Biotechnol; 1995; 43(4):610-6. PubMed ID: 7546601
[TBL] [Abstract][Full Text] [Related]
14. Testing antivirals against hepatitis delta virus: farnesyl transferase inhibitors.
Bordier BB; Glenn JS
Methods Mol Med; 2004; 96():539-53. PubMed ID: 14762290
[No Abstract] [Full Text] [Related]
15. Synthesis of C-11 methyl-substituted benzocycloheptapyridine inhibitors of farnesyl protein transferase.
Njoroge FG; Vibulbhan B; Wong JK; White SK; Wong SC; Carruthers NI; Kaminski JJ; Doll RJ; Girijavallabhan V; Ganguly AK
Org Lett; 1999 Nov; 1(9):1371-3. PubMed ID: 10825985
[TBL] [Abstract][Full Text] [Related]
16. The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.
Tucker TJ; Abrams MT; Buser CA; Davide JP; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hartman GD; Huber HE; Liu D; Lobell RB; Lumma WC; Robinson RG; Sisko JT; Smith AM
Bioorg Med Chem Lett; 2002 Aug; 12(15):2027-30. PubMed ID: 12113834
[TBL] [Abstract][Full Text] [Related]
17. A protein-farnesyl transferase inhibitor interferes with the serum-induced conversion of Candida albicans from a cellular yeast form to a filamentous form.
McGeady P; Logan DA; Wansley DL
FEMS Microbiol Lett; 2002 Jul; 213(1):41-4. PubMed ID: 12127486
[TBL] [Abstract][Full Text] [Related]
18. Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer.
Johnston SR
Lancet Oncol; 2001 Jan; 2(1):18-26. PubMed ID: 11905614
[TBL] [Abstract][Full Text] [Related]
19. Potent, non-thiol inhibitors of farnesyltransferase.
Breslin MJ; deSolms SJ; Giuliani EA; Stokker GE; Graham SL; Pompliano DL; Mosser SD; Hamilton KA; Hutchinson JH
Bioorg Med Chem Lett; 1998 Dec; 8(23):3311-6. PubMed ID: 9873725
[TBL] [Abstract][Full Text] [Related]
20. Diaryl ether inhibitors of farnesyl-protein transferase.
Mactough SC; Desolms SJ; Shaw AW; Abrams MT; Ciccarone TM; Davide JP; Hamilton KA; Hutchinson JH; Koblan KS; Kohl NE; Lobell RB; Robinson RG; Graham SL
Bioorg Med Chem Lett; 2001 May; 11(10):1257-60. PubMed ID: 11392531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
